New York A09156 prohibits the sale of products containing 7-hydroxymitragynine above specified levels and sets fines for violations.
New York A09156 amends the general business law to prohibit the sale of products containing 7-hydroxymitragynine at levels exceeding 2% of total alkaloids or one milligram per serving. This applies to all forms of sale, offer for sale, delivery, or distribution of such products. Businesses found in violation face civil penalties of up to $500 for a first offense and $1,000 for each subsequent violation. All funds collected from these penalties will be deposited into the New York state drug treatment and public education fund.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.